Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
South San Francisco, CA — October 16, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Read moreSouth San Francisco, CA — October 16, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX:
Read more